Ken Griffin Options Holdings

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
PB
Prosperity Bancshares Inc

Financial Services
PUT
$67,000
1.1K
Q2 2024
Reduced 81.03%
PTGX
Protagonist Therapeutics, Inc

Healthcare
CALL
$256,000
7.4K
Q2 2024
Reduced 47.22%
PTGX
Protagonist Therapeutics, Inc

Healthcare
PUT
$263,000
7.6K
Q2 2024
Reduced 47.22%
PLX
Protalix Bio Therapeutics, Inc.

Healthcare
CALL
$64,000
55.1K
Q2 2024
Reduced 54.46%
PLX
Protalix Bio Therapeutics, Inc.

Healthcare
PUT
$5,000
4.6K
Q2 2024
Reduced 54.46%
TARA
Protara Therapeutics, Inc.

Healthcare
CALL
$17,000
8.4K
Q2 2024
Reduced 31.82%
TARA
Protara Therapeutics, Inc.

Healthcare
PUT
$3,000
1.5K
Q2 2024
Reduced 31.82%
PRTA
Prothena Corp Public LTD CO

Healthcare
CALL
$344,000
16.7K
Q2 2024
Added 12.08%
PRTA
Prothena Corp Public LTD CO

Healthcare
PUT
$555,000
26.9K
Q2 2024
Added 12.08%
PRLB
Proto Labs Inc

Industrials
CALL
$1.27 Million
41.1K
Q2 2024
Added 104.17%
PVBC
Provident Bancorp, Inc.

Financial Services
CALL
$269,000
26.4K
Q2 2024
Reduced 2.94%
PFS
Provident Financial Services Inc

Financial Services
CALL
$124,000
8.7K
Q2 2024
Added 73.68%
PFS
Provident Financial Services Inc

Financial Services
PUT
$47,000
3.3K
Q2 2024
Added 73.68%
PUK
Prudential PLC

Financial Services
CALL
$62,000
3.4K
Q2 2024
Added 9.95%
PUK
Prudential PLC

Financial Services
PUT
$749,000
40.9K
Q2 2024
Added 9.95%
PTC
Ptc Inc.

Technology
CALL
$8.68 Million
47.8K
Q2 2024
Reduced 20.83%
PTC
Ptc Inc.

Technology
PUT
$1.38 Million
7.6K
Q2 2024
Reduced 20.83%
PTCT
Ptc Therapeutics, Inc.

Healthcare
CALL
$262,000
8.6K
Q2 2024
Reduced 24.19%
PTCT
Ptc Therapeutics, Inc.

Healthcare
PUT
$143,000
4.7K
Q2 2024
Reduced 24.19%
PSA
Public Storage

Real Estate
CALL
$11.4 Million
39.6K
Q2 2024
Reduced 35.51%
PSA
Public Storage

Real Estate
PUT
$15.6 Million
54.3K
Q2 2024
Reduced 35.51%
PEG
Public Service Enterprise Group Inc

Utilities
CALL
$9.24 Million
125K
Q2 2024
Added 2.01%
PEG
Public Service Enterprise Group Inc

Utilities
PUT
$14.2 Million
192K
Q2 2024
Added 2.01%
PUBM
Pub Matic, Inc.

Technology
CALL
$4.29 Million
211K
Q2 2024
Reduced 33.12%
PUBM
Pub Matic, Inc.

Technology
PUT
$3.01 Million
148K
Q2 2024
Reduced 33.12%
LUNG
Pulmonx Corp

Healthcare
CALL
$2,000
400
Q2 2024
Reduced 66.67%
PLSE
Pulse Biosciences, Inc.

Healthcare
CALL
$109,000
9.8K
Q2 2024
Reduced 7.95%
PLSE
Pulse Biosciences, Inc.

Healthcare
PUT
$543,000
48.6K
Q2 2024
Reduced 7.95%
PBYI
Puma Biotechnology, Inc.

Healthcare
CALL
$10,000
3.3K
Q2 2024
Reduced 96.87%
PBYI
Puma Biotechnology, Inc.

Healthcare
PUT
$60,000
18.5K
Q2 2024
Reduced 96.87%
PSTG
Pure Storage, Inc.

Technology
PUT
$17 Million
265K
Q2 2024
Reduced 43.43%
PCT
Pure Cycle Technologies, Inc.

Industrials
CALL
$5.33 Million
900K
Q2 2024
Added 152.32%
PCT
Pure Cycle Technologies, Inc.

Industrials
PUT
$4.77 Million
806K
Q2 2024
Added 152.32%
PPBT
Purple Biotech Ltd.

Healthcare
CALL
$2,000
5.6K
Q2 2024
Reduced 15.15%
PRPL
Purple Innovation, Inc.

Consumer Cyclical
CALL
$35,000
34.4K
Q2 2024
Reduced 87.11%
PRPL
Purple Innovation, Inc.

Consumer Cyclical
PUT
$11,000
10.7K
Q2 2024
Reduced 87.11%
PVH
Pvh Corp.

Consumer Cyclical
PUT
$20 Million
189K
Q2 2024
Added 387.89%
PYXS
Pyxis Oncology, Inc.

Healthcare
CALL
$29,000
9K
Q2 2024
Reduced 66.67%
PYXS
Pyxis Oncology, Inc.

Healthcare
PUT
$16,000
5K
Q2 2024
Reduced 66.67%
QTWO
Q2 Holdings, Inc.

Technology
CALL
$1.54 Million
25.5K
Q2 2024
Added 117.72%
QTWO
Q2 Holdings, Inc.

Technology
PUT
$1.04 Million
17.2K
Q2 2024
Added 117.72%
Q32 Bio Inc
CALL
$0
160
Q2 2024
Reduced 86.03%
Qiagen Nv
CALL
$0
67.8K
Q2 2024
Reduced 30.63%
Qiagen Nv
PUT
$0
21.8K
Q2 2024
Reduced 30.63%
QFIN
360 Digi Tech, Inc.

Financial Services
CALL
$554,000
28.1K
Q2 2024
Reduced 41.55%
QFIN
360 Digi Tech, Inc.

Financial Services
PUT
$641,000
32.5K
Q2 2024
Reduced 41.55%
QRVO
Qorvo, Inc.

Technology
CALL
$14.7 Million
127K
Q2 2024
Added 36.98%
QRVO
Qorvo, Inc.

Technology
PUT
$6.83 Million
58.9K
Q2 2024
Added 36.98%
QUAD
Quad/Graphics, Inc.

Industrials
CALL
$256,000
47K
Q2 2024
Reduced 16.46%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 17,024
  • Current Value $483 Billion
  • Prior Value $509 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1,061 stocks
  • Additional Purchases 2,429 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,297 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email